Race Oncology Ltd (RAC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.093x

Based on the latest financial reports, Race Oncology Ltd (RAC) has a cash flow conversion efficiency ratio of -0.093x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.19 Million ≈ $-1.55 Million USD) by net assets (AU$23.57 Million ≈ $16.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Race Oncology Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Race Oncology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Race Oncology Ltd for a breakdown of total debt and financial obligations.

Race Oncology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Race Oncology Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Taiwan Optical Platform Co Ltd TW:6464	0.038x
Steelcast Limited NSE:STEELCAS	0.025x
Hansae Co KO:105630	0.138x
M3-Brigade Acquisition V Corp. Class A Ordinary shares NASDAQ:MBAV	-0.001x
Greenpanel Industries Limited NSE:GREENPANEL	0.047x
Transcontinental Realty Investors NYSE:TCI	0.010x
Kizilbuk Gayrimenkul Yatirim Ortakligi AS IS:KZBGY	0.029x
Strattec Security Corporation NASDAQ:STRT	0.053x

Annual Cash Flow Conversion Efficiency for Race Oncology Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Race Oncology Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Race Oncology Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$16.01 Million ≈ $11.33 Million	AU$-4.57 Million ≈ $-3.24 Million	-0.286x	+45.19%
2024-06-30	AU$18.31 Million ≈ $12.96 Million	AU$-9.55 Million ≈ $-6.75 Million	-0.521x	-24.73%
2023-06-30	AU$25.49 Million ≈ $18.03 Million	AU$-10.65 Million ≈ $-7.54 Million	-0.418x	-141.15%
2022-06-30	AU$36.11 Million ≈ $25.55 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.173x	+49.37%
2021-06-30	AU$13.72 Million ≈ $9.71 Million	AU$-4.70 Million ≈ $-3.32 Million	-0.342x	+20.92%
2020-06-30	AU$5.69 Million ≈ $4.03 Million	AU$-2.46 Million ≈ $-1.74 Million	-0.433x	+18.25%
2019-06-30	AU$5.05 Million ≈ $3.57 Million	AU$-2.67 Million ≈ $-1.89 Million	-0.530x	-8.53%
2018-06-30	AU$7.93 Million ≈ $5.61 Million	AU$-3.87 Million ≈ $-2.74 Million	-0.488x	-11.53%
2017-06-30	AU$5.64 Million ≈ $3.99 Million	AU$-2.47 Million ≈ $-1.74 Million	-0.437x	-482.87%
2016-06-30	AU$4.08 Million ≈ $2.89 Million	AU$-306.06K ≈ $-216.56K	-0.075x	+99.59%
2015-06-30	AU$5.69K ≈ $4.02K	AU$-103.69K ≈ $-73.37K	-18.233x	-3337.39%
2014-06-30	AU$-70.24K ≈ $-49.70K	AU$-39.56K ≈ $-27.99K	0.563x	+1402.35%
2013-12-31	AU$98.97 Million ≈ $70.02 Million	AU$3.71 Million ≈ $2.63 Million	0.037x	+284.33%
2013-06-30	AU$93.38K ≈ $66.07K	AU$-1.90K ≈ $-1.34K	-0.020x	-128.73%
2012-06-30	AU$94.45 Million ≈ $66.83 Million	AU$6.68 Million ≈ $4.73 Million	0.071x	-36.42%
2011-06-30	AU$107.05 Million ≈ $75.74 Million	AU$11.92 Million ≈ $8.43 Million	0.111x	--

About Race Oncology Ltd

AU:RAC Australia Biotechnology

Market Cap

$309.47 Million

AU$437.38 Million AUD

Market Cap Rank

#14840 Global

#395 in Australia

Share Price

AU$2.40

Change (1 day)

-8.05%

52-Week Range

AU$1.13 - AU$4.70

All Time High

AU$4.70